UC San Diego School of Medicine, Weill Cornell Medicine and Stanford Medicine have launched a three-year study to investigate new ways to treat or prevent major depression, accelerate effective treatments and develop predictive models to identify which treatments work best for individual patients.
Related Articles

News
Celebrating 10 Years of UC San Diego’s Physical, Cultural and Intellectual Transformation
June 9, 2022
sandiegobiotech
News, UCSD News
Comments Off on Celebrating 10 Years of UC San Diego’s Physical, Cultural and Intellectual Transformation
UC San Diego is experiencing a significant and exciting transformation. Multiple projects are underway across the region to enhance UC San Diego’s presence as a premier destination for students, employees, healt… […]

News
Later Hit: Does Cannabis Ease Pain, Speed Recovery in Injured Athletes?
February 1, 2022
sandiegobiotech
News, UCSD News
Comments Off on Later Hit: Does Cannabis Ease Pain, Speed Recovery in Injured Athletes?
The National Football League is funding a novel clinical trial by UC San Diego researchers to assess whether cannabis or CBD provide any post-game pain relief caused by athletic injury. Trial participants will b… […]

News
Supercomputer Simulations Help Optimize Floating Wind Farms
September 18, 2019
sandiegobiotech
News
Comments Off on Supercomputer Simulations Help Optimize Floating Wind Farms